Oncologic Outcomes of Parenchyma-Sparing Resection for Hepatoblastoma

In brief

This study compares parenchyma-sparing resection (PSR) to standard resection techniques for hepatoblastoma, examining whether tissue-conserving approaches can achieve comparable oncologic outcomes. The research addresses an evolving surgical paradigm in pediatric liver tumor management.

• Surgery remains the primary curative treatment for hepatoblastoma in pediatric patients.
• Parenchyma-sparing resection is gaining acceptance as an alternative to traditional hemi-hepatectomy or trisectionectomy.
• PSR aims to preserve functional liver tissue while achieving oncologic control in hepatoblastoma cases.
• Comparative outcomes data between PSR and standard resection approaches are needed to guide surgical decision-making.

Written by the GCMD Library team from the article.